Publications

Intersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022

JCO Glob Oncol. 2024 Oct;10:e2400238. doi: 10.1200/GO.24.00238. Epub 2024 Oct 3

Time to Update-Requesting Inclusive Submission Categories for Oncology Research

JCO Glob Oncol. 2024 Aug;10:e2400136. doi: 10.1200/GO.24.00136

ESMO-Magnitude of Clinical Benefit Scale (MCBS) scores for Phase III trials of adjuvant and curative therapies at the 2022 ASCO Annual Meeting (ASCO22)

Presented at ESMO-Asia 2023
December 1, 2023

Application of ESMO-MCBS for assessment of metastatic solid tumor phase III study abstracts presented at ASCO annual meeting 2022

Presented at ESMO-Asia 2023
December 1, 2023

Country and gender representation in abstracts at the 2022 ASCO meeting

Presented at ESMO-Asia 2022
Dec 4, 2022